Proreo Pharma Innovation AG
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Proreo Pharma Innovation AG
Two companies specialising in bacteriophage technologies are to join forces as AmpliPhi, which has operations in the UK and US, prepares to acquire Sydney, Australia-based Special Phage Services (SPS). The all-share transaction will create "the world's leading anti-infective company focused on bacteriophage-based therapies", they claim.
- Specialty Pharmaceuticals
- Other Names / Subsidiaries